Skip to content
Cerulean Pharma
Menu
  • Home
  • About
    • Overview: The Company
    • Investors
    • Our Core Values
  • Science & Technology
    • Technology Overview
    • Nanopharmaceuticals
    • Competitive Advantage
    • Background Publications
  • Clinical Trials
  • Careers
    • Careers
    • Open Positions
  • News & Press
    • News and Press Releases
    • Media Kit
  • Contact Us

INSTITUTIONAL INVESTORS

Cerulean is backed by leading venture firms

 

Polaris Venture Partners
www.polarisventures.com

Venrock
www.venrock.com

Lilly Ventures
www.lillyventures.com

Lux Capital
www.luxcapital.com

Bessemer Venture Partners
www.bvp.com

OTHER NON- INSTITUTIONAL INVESTORS

William Rastetter, Ph.D.

Alexandria Real Estate Equities, Inc.

 

Our mission is to dramatically enhance patient outcome in diseases with high unmet medical need through innovative nanopharmaceuticals, resulting in medicines with superior efficacy and tolerability.

Copyright 2023 © Cerulean Pharma Inc. 840 Memorial Drive, 5th Floor, Cambridge, MA 02139 p 617 551 9600 f 617 494 1544